Close

Viridian Therapeutic (VRDN) PT Raised to $38 at Oppenheimer

March 26, 2021 9:27 AM EDT Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $38.00 (from $37.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login